Insulin aspart, recombinant Subcutaneous and Risedronate and Calcium
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Risedronate and Calcium and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: calcium carbonate / risedronate
Brand name: Actonel and Calcium, Actonel with Calcium
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Risedronate Delayed Release
- Insulin aspart, recombinant Subcutaneous-Risedronate Delayed-Release Tablets
- Insulin aspart, recombinant Subcutaneous-Risedronate Sodium
- Insulin aspart, recombinant Subcutaneous-Risedronate Tablets
- Insulin aspart, recombinant Subcutaneous-Risperdal
- Insulin aspart, recombinant Subcutaneous-Risperdal (Risperidone Oral Solution)
- Risedronate and Calcium-Insulin degludec
- Risedronate and Calcium-Insulin Degludec (U-100) Prefilled Pens
- Risedronate and Calcium-Insulin Degludec (U-100) Vials
- Risedronate and Calcium-Insulin Degludec (U-200) Prefilled Pens
- Risedronate and Calcium-Insulin degludec and liraglutide
- Risedronate and Calcium-Insulin degludec and liraglutide Subcutaneous